GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3043% above fair value
$45.46−3.78 (-7.68%)
Close on Nov 20, 2026Market cap $1.36BP/E –Yield –
GeneDx net income
Net income is the profit left for shareholders after every expense, interest and tax.
GeneDx's net income for the twelve months ending Jun 30, 2026 was -$106.36M, down 7664.5% year over year. For fiscal 2025 it was -$21.02M. The highest annual figure on record is -$21.02M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.02M | – |
| FY2024 | Dec 31, 2024 | -$52.29M | – |
| FY2023 | Dec 31, 2023 | -$175.77M | – |
| FY2022 | Dec 31, 2022 | -$548.98M | – |
| FY2021 | Dec 31, 2021 | -$245.39M | – |
| FY2020 | Dec 31, 2020 | -$241.34M | – |
| FY2019 | Dec 31, 2019 | -$29.70M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.74M | -264.1% |
| Q1 FY2026 | Mar 31, 2026 | -$63.32M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.67M | -424.9% |
| Q3 FY2025 | Sep 30, 2025 | -$7.64M | – |
| Q2 FY2025 | Jun 30, 2025 | $10.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.53M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.44M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$29.17M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$25.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$42.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$46.72M | – |
| Q1 FY2023 | Mar 31, 2023 | -$60.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$308.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$77.58M | -337.0% |
| Q2 FY2022 | Jun 30, 2022 | -$85.74M | – |
| Q1 FY2022 | Mar 31, 2022 | -$76.90M | – |
| Q4 FY2021 | Dec 31, 2021 | -$40.19M | – |
| Q3 FY2021 | Sep 30, 2021 | $32.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$46.16M | – |
| Q1 FY2021 | Mar 31, 2021 | -$191.78M | – |
| Q4 FY2020 | Dec 31, 2020 | -$125.68M | – |
| Q3 FY2020 | Sep 30, 2020 | -$56.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$32.05M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.99M | – |
See a number that looks wrong?